Drugs of Abuse Screen, DAU9, Urine
Detecting drug abuse involving amphetamines, barbiturates, benzodiazepines, cocaine, opiates, phencyclidine, tetrahydrocannabinol, and methadone
This test is intended to be used in a setting where the test results can be used to make a definitive diagnosis
Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test
This test uses immunologic testing for drugs by class and screens for the presence of amphetamines, barbiturates, benzodiazepines, cocaine metabolite, methadone, opiates, phencyclidine, and tetrahydrocannabinol in urine. Positive immunologic results are confirmed by gas chromatography-mass spectrometry or liquid chromatography-tandem mass spectrometry.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
The specific drug identified will be reported.
Enzyme-multiplied immunoassay technique cutoff concentrations:
Amphetamines: 500 ng/mL
Barbiturates: 200 ng/mL
Benzodiazepines: 200 ng/mL
Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL
Methadone: 300 ng/mL
Opiates: 300 ng/mL
Phencyclidine: 25 ng/mL
Tetrahydrocannabinol carboxylic acid: 50 ng/mL
Results of this test are confirmed and should be considered definitive.
A positive result indicates that the patient has used the drugs detected in the recent past.
For information about drug testing, including estimated detection times, see Drugs of Abuse Testing at http://www.mayomedicallaboratories.com/articles/drug-book/index.html
Creatinine and specific gravity are measured as indicators of specimen dilution.
Cautions Discusses conditions that may cause diagnostic confusion, including improper specimen collection and handling, inappropriate test selection, and interfering substances
Not intended for use in employment-related testing.
The test does not screen for drug classes other than those listed above. More comprehensive screening is available using the serum or urine drug screens (CDAS / Drug Screen, Prescription/OTC, Serum or CDAUN / Drug Screen, Prescription/OTC, Urine).
Clinical Reference Provides recommendations for further in-depth reading of a clinical nature
Porter WF, Moyer TP: Clinical toxicology. In Tietz Textbook of Clinical Chemistry. Fourth edition. Edited by CA Burtis, ER Ashwood. Philadelphia, WB Saunders Company, 1993, pp 1155-1235